Mike R. Sather

649 total citations
23 papers, 287 citations indexed

About

Mike R. Sather is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Statistics, Probability and Uncertainty. According to data from OpenAlex, Mike R. Sather has authored 23 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Statistics, Probability and Uncertainty. Recurrent topics in Mike R. Sather's work include Meta-analysis and systematic reviews (5 papers), Opioid Use Disorder Treatment (4 papers) and Ethics in Clinical Research (4 papers). Mike R. Sather is often cited by papers focused on Meta-analysis and systematic reviews (5 papers), Opioid Use Disorder Treatment (4 papers) and Ethics in Clinical Research (4 papers). Mike R. Sather collaborates with scholars based in United States, Australia and India. Mike R. Sather's co-authors include Dennis W. Raisch, Kathy D. Boardman, Carol L. Fye, Paul J. Fudala, Walter Ling, Stuart Warren, Alissa R. Segal, William G. Troutman, John George and Roberta Kahn and has published in prestigious journals such as Quality of Life Research, Drug and Alcohol Dependence and Diabetes Research and Clinical Practice.

In The Last Decade

Mike R. Sather

20 papers receiving 270 citations

Peers

Countries citing papers authored by Mike R. Sather

Since Specialization

Citations

This map shows the geographic impact of Mike R. Sather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike R. Sather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike R. Sather more than expected).

Fields of papers citing papers by Mike R. Sather

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike R. Sather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike R. Sather. The network helps show where Mike R. Sather may publish in the future.

Co-authorship network of co-authors of Mike R. Sather

This figure shows the co-authorship network connecting the top 25 collaborators of Mike R. Sather. A scholar is included among the top collaborators of Mike R. Sather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike R. Sather. Mike R. Sather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Department of Veterans Affairs Cooperative Studies Program clinical trials on practice guidelines for high blood pressure management 2018 ·Contemporary Clinical Trials Communications ·(unknown), Mike R. Sather, Ludmila N. Bakhireva, James J. Nawarskas, Kathy D. Boardman, Grant D. Huang	3
2	Total integrated performance excellence system (TIPES): A true north direction for a clinical trial support center 2017 ·Contemporary Clinical Trials Communications ·Mike R. Sather, (unknown), Kathy D. Boardman, Stuart Warren, Anne Davis‐Karim, (unknown), (unknown), (unknown), Stanley H. Johnson, Julia E. Vertrees, (unknown), (unknown), Grant D. Huang	0
3	Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes 2013 ·Diabetes Research and Clinical Practice ·(unknown), Nasreen Khan, Dennis W. Raisch, Matthew E. Borrego, Mike R. Sather, Glen H. Murata	3
4	Health-related quality of life changes associated with buprenorphine treatment for opioid dependence 2011 ·Quality of Life Research ·Dennis W. Raisch, (unknown), (unknown), Mark Jones, Mike R. Sather, (unknown), Walter Ling	27
5	Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation. 2008 ·PubMed ·(unknown), Dennis W. Raisch, Mike R. Sather, Alissa R. Segal, Stuart Warren, (unknown)	14
6	Pharmacy Students' Knowledge, Attitudes, and Evaluation of Direct-to-Consumer Advertising 2007 ·American Journal of Pharmaceutical Education ·(unknown), Matthew E. Borrego, Gireesh V. Gupchup, (unknown), Mike R. Sather	9
7	A Comparison of Veteran and Nonveteran Motivations and Reasons for Participating in Clinical Trials 2007 ·Military Medicine ·(unknown), Dennis W. Raisch, Mike R. Sather, Stuart Warren, Alissa R. Segal	23
8	Pharmacy Students' Knowledge, Attitudes, and Evaluation of Direct-to-Consumer Advertising 2007 ·American Journal of Pharmaceutical Education ·(unknown), Matthew E. Borrego, Gireesh V. Gupchup, (unknown), Mike R. Sather	1
9	Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence 2006 ·Drug and Alcohol Dependence ·Ahmed Elkashef, Paul J. Fudala, (unknown), Shou-Hua Li, Roberta Kahn, Nora Chiang, Frank J. Vocci, Joseph Collins, Karen Jones, Kathy D. Boardman, Mike R. Sather	40
10	GI Risk Factors and Use of GI Protective Agents Among Patients Receiving Nonsteroidal Antiinflammatory Drugs 2006 ·Annals of Pharmacotherapy ·Crystal L. Harris, Dennis W. Raisch, (unknown), (unknown), (unknown), Mike R. Sather	7
11	Assessment of the impact of a patient clinical trialshandbook among pharmacy students 2005 ·Clinical Therapeutics ·(unknown), Dennis W. Raisch, Carol L. Fye, Mike R. Sather	4
12	Pharmacists’ and Technicians’ Perceptions and Attitudes Toward Dispensing Buprenorphine/Naloxone to Patients with Opioid Dependence 2005 ·Journal of the American Pharmacists Association ·Dennis W. Raisch, Paul J. Fudala, Andrew J. Saxon, (unknown), Paul Casadonte, Walter Ling, Bankole A. Johnson, (unknown), Patricia Isbell Ordorica, William O. Williford, Mike R. Sather	35
13	Promoting good clinical practices in the conduct of clinical trials: experiences in the department of veterans affairs cooperative studies program 2003 ·Controlled Clinical Trials ·Mike R. Sather, Dennis W. Raisch, Clair Haakenson, (unknown), John R. Feussner	15
14	The role of the pharmacy coordinating center in the DIG trial 2003 ·Controlled Clinical Trials ·Carol L. Fye, (unknown), Dennis W. Raisch, (unknown), Mike R. Sather, (unknown), (unknown), Rekha Garg, Salim Yusuf, William O. Williford, (unknown)	3
15	Opioid Dependence Treatment, Including Buprenorphine/Naloxone 2002 ·Annals of Pharmacotherapy ·Dennis W. Raisch, Carol L. Fye, Kathy D. Boardman, Mike R. Sather	58
16	Variability in the assessment of adverse events in a multicenter clinical trial 2001 ·Clinical Therapeutics ·Dennis W. Raisch, William G. Troutman, Mike R. Sather, Paul J. Fudala	19
17	Masking drug treatments in the Cardiac Arrhythmia Pilot Study (CAPS) 1996 ·Controlled Clinical Trials ·Clair Haakenson, Toshio Akiyama, Alfred P. Hallstrom, Mike R. Sather	2
18	The investigator-sponsored IND in clinical trials 1987 ·Controlled Clinical Trials ·Clair Haakenson, Carol L. Fye, Mike R. Sather, (unknown)	1
19	Pressure Sores and the Spinal Cord Injury Patient 1977 ·Drug Intelligence & Clinical Pharmacy ·Mike R. Sather, (unknown), John George	15
20	Discharge Medication Counseling: How to Enhance Patient Compliance with Prescribed Medication Regimens 1976 ·Hospital Topics ·(unknown), Mike R. Sather	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact